TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 412 | 447 | 395 |
Financial expenses | 11 | 14 | 17 |
Earnings before taxes | -5 | -2 | -2 |
EBITDA | 50 | 62 | 65 |
Total assets | 248 | 319 | 351 |
Current assets | 72 | 80 | 57 |
Current liabilities | 68 | 127 | 165 |
Equity capital | 35 | 44 | 47 |
- share capital | 9 | 10 | 10 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 14.1% | 13.8% | 13.4% |
Turnover per employee | 206 | 224 | 198 |
Profit as a percentage of turnover | -1.2% | -0.4% | -0.5% |
Return on assets (ROA) | 2.4% | 3.8% | 4.3% |
Current ratio | 105.9% | 63.0% | 34.5% |
Return on equity (ROE) | -14.3% | -4.5% | -4.3% |
Change turnover | 1 | 60 | -7 |
Change turnover % | 0% | 15% | -2% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.